Definium 制药 DFTX
$33.27 +$2.91 (+9.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $33.42 +0.45%
开盘$31.23
昨收$30.36
当日区间$30.91 – $33.42
成交量1.28M
市值$4.47B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$75.08M-83.5% YoY
净利润-$158.99M-271.9% YoY
摊薄每股收益-$1.44-188.0% YoY
自由现金流-$52.78M-78.3% YoY
经营现金流-$52.78M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-64.1%
资产收益率-51.3%
投入资本回报率-61.2%
流动比率6.95
负债/资产比率17.5%
现金及投资$1.08B
总负债$36.47M
净现金（净负债）$1.05B
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $75.08M | $59.22M | $166.31M | $47.58M | $45.67M |
| 销售及管理费用 | $26.41M | $17.74M | $48.64M | $14.06M | $14.69M |
| -管理费用 | $26.41M | $17.74M | $48.64M | $14.06M | $14.69M |
| 研发费用 | $48.67M | $41.48M | $117.67M | $33.52M | $30.98M |
| 营业利润 | -$75.08M | -$59.22M | -$166.31M | -$47.58M | -$45.67M |
| 非经营性利息净收入（支出） | $2.35M | $2.21M | $5.48M | $2.22M | $988,000.00 |
| 非经营性利息收入 | $3.59M | $3.46M | $10.96M | $3.49M | $2.26M |
| 非经营性利息支出 | $1.23M | $1.25M | $5.48M | $1.27M | $1.27M |
| 其他收入（支出） | -$86.26M | -$20.09M | -$22.96M | -$5.08M | -$22.58M |
| 证券出售收益 | -$86.26M | -$20.09M | -$22.96M | -$5.08M | -$22.58M |
| 税前利润 | -$158.99M | -$77.10M | -$183.79M | -$50.44M | -$67.27M |
| 净利润 | -$158.99M | -$77.10M | -$183.79M | -$50.44M | -$67.27M |
| 持续经营利润 | -$158.99M | -$77.10M | -$183.79M | -$50.44M | -$67.27M |
| 归属母公司净利润 | -$158.99M | -$77.10M | -$183.79M | -$50.44M | -$67.27M |
| 归属普通股股东净利润 | -$158.99M | -$77.10M | -$183.79M | -$50.44M | -$67.27M |
| 基本每股收益 | -$1.44 | -$0.71 | -$2.06 | -$0.50 | -$0.78 |
| 摊薄每股收益 | -$1.44 | -$0.71 | -$2.06 | -$0.50 | -$0.78 |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.11B | $401.29M | $440.10M | $440.10M | $236.92M |
| 流动资产合计 | $1.09B | $380.56M | $419.32M | $419.32M | $215.85M |
| 现金及现金等价物与短期投资 | $1.08B | $373.42M | $411.59M | $411.59M | $209.07M |
| -现金及现金等价物 | $655.27M | $262.52M | $257.84M | $257.84M | $19.96M |
| -短期投资 | $428.61M | $110.90M | $153.76M | $153.76M | $189.11M |
| 其他流动资产 | $8.22M | $7.14M | $7.73M | $7.73M | $6.78M |
| 非流动资产合计 | $20.80M | $20.73M | $20.78M | $20.78M | $21.07M |
| 商誉及其他无形资产 | $19.92M | $19.92M | $19.92M | $19.92M | $19.92M |
| -商誉 | $19.92M | $19.92M | $19.92M | $19.92M | $19.92M |
| 其他非流动资产 | $880,000.00 | $812,000.00 | $862,000.00 | $862,000.00 | $1.15M |
| 负债合计 | $194.22M | $122.44M | $107.77M | $107.77M | $106.32M |
| 流动负债合计 | $157.20M | $81.11M | $66.70M | $66.70M | $65.42M |
| 应付款 | $6.97M | $7.13M | $5.35M | $5.35M | $8.11M |
| -应付账款 | $6.97M | $7.13M | $5.35M | $5.35M | $8.11M |
| 一年内应计费用 | $17.12M | $17.10M | $10.98M | $10.98M | $11.70M |
| 其他流动负债 | $113.02M | $49.47M | $40.91M | $40.91M | $38.28M |
| 非流动负债合计 | $37.02M | $41.33M | $41.08M | $41.08M | $40.90M |
| 长期债务及融资租赁负债 | $36.47M | $40.77M | $40.58M | $40.58M | $40.39M |
| -长期债务 | $36.47M | $40.77M | $40.58M | $40.58M | $40.39M |
| 其他非流动负债 | $549,000.00 | $559,000.00 | $496,000.00 | $496,000.00 | $519,000.00 |
| 股东权益合计 | $918.68M | $278.85M | $332.33M | $332.33M | $130.60M |
| 股东权益 | $918.68M | $278.85M | $332.33M | $332.33M | $130.60M |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.74B | $937.80M | $913.91M | $913.91M | $661.83M |
| 留存收益 | -$818.76M | -$659.77M | -$582.67M | -$582.67M | -$532.24M |
| 不影响留存收益的损益 | $417,000.00 | $824,000.00 | $1.09M | $1.09M | $1.00M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$52.78M | -$42.63M | -$131.56M | -$42.98M | -$29.57M |
| 持续经营经营活动现金流净额 | -$52.78M | -$42.63M | -$131.56M | -$42.98M | -$29.57M |
| 持续经营净利润 | -$158.99M | -$77.10M | -$183.79M | -$50.44M | -$67.27M |
| 持续经营损益 | $86.22M | $20.05M | $22.83M | $5.06M | $22.54M |
| 其他非现金项目 | $4.66M | $1.25M | $1.69M | $632,000.00 | $3.52M |
| 营运资金变动 | $6.28M | $5.45M | $9.44M | -$4.29M | $8.10M |
| -预付资产变动 | -$264,000.00 | $585,000.00 | $152,000.00 | -$2.44M | $854,000.00 |
| -应付账款及应计费用变动 | $6.69M | $4.77M | $9.30M | -$1.84M | $7.25M |
| -其他流动资产变动 | -$133,000.00 | $118,000.00 | $30,000.00 | $17,000.00 | $11,000.00 |
| -其他流动负债变动 | -$10,000.00 | -$29,000.00 | -$40,000.00 | -$23,000.00 | -$22,000.00 |
| 投资活动现金流净额 | -$316.74M | $42.00M | -$151.61M | $34.98M | $15.41M |
| 持续经营投资活动现金流净额 | -$316.74M | $42.00M | -$151.61M | $34.98M | $15.41M |
| 投资购置及出售净额 | -$316.74M | $42.00M | -$151.61M | $34.98M | $15.41M |
| 筹资活动现金流 | $762.27M | $5.31M | $267.27M | $245.87M | $749,000.00 |
| 持续经营筹资活动现金流净额 | $762.27M | $5.31M | $267.27M | $245.87M | $749,000.00 |
| 普通股发行净额 | $804.72M | $276,000.00 | $258.86M | $258.86M | $0.00 |
| 股票期权行使所得 | -$2.69M | $5.03M | $1.04M | -$811,000.00 | $1.33M |
| 期末现金余额 | $655.27M | $262.52M | $257.84M | $257.84M | $19.96M |
| 现金净变动 | $392.75M | $4.68M | -$15.90M | $237.88M | -$13.41M |
| 期初现金余额 | $262.52M | $257.84M | $273.74M | $19.96M | $33.39M |
| 汇率变动影响 | -$1,000.00 | $3,000.00 | -$7,000.00 | $1,000.00 | -$21,000.00 |
| 自由现金流 | -$52.78M | -$42.63M | -$131.56M | -$42.98M | -$29.57M |
| 折旧、折耗与摊销 | – | – | $0.00 | $0.00 | – |
| 债务发行及偿还净额 | – | – | $20.00M | $0.00 | $447,000.00 |
| 其他筹资费用净额 | – | – | -$12.63M | -$12.18M | -$1.03M |
暂无评论——快来第一个聊聊 DFTX。
登录后参与讨论。